Clinical Trial Update: Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of tocilizumab added to DMARD therapy in adults with moderate to severe rheumatoid arthritis. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED